Adverse reactions and efficacy of camrelizumab in patients with lung adenocarcinoma with high PD-L1 expression: A case report

Tingting Wei(Ningxia Medical University), Xinlan Liu(Yunnan Agricultural University), Zhisheng Wang
Medicine
February 17, 2023
Cited by 6


Related Papers